David D. Chang - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Allogene Therapeutics, Inc. (ALLO)

Filing Manager
Chang David D
Reporting Manager
David D. Chang, M.D., Ph.D.
Security
Allogene Therapeutics, Inc. Common Stock
Symbol
ALLO
Shares outstanding
214M shares
Disclosed Ownership
10.9M shares
Ownership
5.1%
Form type
SCHEDULE 13G/A
Date filed
2/13/2025, 04:29 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
David D. Chang, M.D., Ph.D. 5.1% 10.9M 7.99M 2.91M /s/ David D. Chang David D. Chang, M.D., Ph.D.
Chang 2006 Family Trust 0.6% 1.2M 0 1.2M /s/ David D. Chang By David D. Chang, M.D., Ph.D., Co-Trustee
JEC 2019 Trust 0.4% 856K 0 856K /s/ David D. Chang By David D. Chang, M.D., Ph.D., Co-Trustee
RTC 2019 Trust 0.4% 856K 856K /s/ David D. Chang By David D. Chang, M.D., Ph.D., Co-Trustee